-
Better Buy: AbbVie Inc. vs. GlaxoSmithKline
Post on 4/6/17
-
The 3 Most Important Numbers for Pfizer Inc.
Post on 4/6/17
-
Meadowlands Veterinary Hospital Opens State of the Art Facility
Post on 4/5/17
-
Here's Why The Best Is Yet to Come for Johnson & Johnson
Post on 4/5/17
-
Johnson & Johnson: Selling And Still Getting Richer
Post on 4/4/17
-
Caladrius Biosciences Adds Four Clinical Sites, Including Joslin Diabetes Center
Post on 4/3/17
-
Matinas BioPharma Reports 2016 Financial Results and Provides Corporate Update
Post on 4/3/17
-
Could Pfizer Buy Esperion Therapeutics?
Post on 4/3/17
-
Here's How Much Johnson & Johnson Will Probably Raise Its Dividend Next Month
Post on 4/3/17
-
3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest
Post on 4/3/17
-
CytoSorbents Announces Pricing of Follow-On Offering
Post on 4/2/17
-
Johnson & Johnson: The Senate Probe And Other Risks
Post on 3/31/17
-
Akers Biosciences Announces a $2 Million Private Placement
Post on 3/31/17
-
A Video Conversation with Rick Bunker, Cofounder and CEO of Prescription Advisory Systems and Technology - Part III
Post on 4/13/17
-
A Video Conversation with Rick Bunker, Cofounder and CEO of Prescription Advisory Systems and Technology - Part II
Post on 4/6/17
-
A Video Conversation with Rick Bunker, Cofounder and CEO of Prescription Advisory Systems and Technology - Part I
Post on 4/4/17
-
Select Medical And Riverside Health Enter Joint Venture
Post on 3/30/17
-
CytoSorbents Announces Proposed Offering of Common Stock
Post on 3/30/17
-
Worried About Johnson & Johnson's Valuation? Consider This Crazy, Undervalued, 4.2% Yielding Pharmaceutical Stock Instead
Post on 3/30/17
-
A Video Conversation with Jonathan Maxim, CEO of Vea Fitness - Part III
Post on 4/24/17
-
A Video Conversation with Jonathan Maxim, CEO of Vea Fitness - Part II
Post on 4/14/17
-
A Video Conversation with Jonathan Maxim, CEO of Vea Fitness - Part I
Post on 4/11/17
-
Pivot Physical Therapy Acquires Dynamic Physical Therapy
Post on 3/29/17
-
Why Shares of Immunomedics Inc Are up an Astounding 89% in 2017
Post on 3/29/17
-
Arno Therapeutics Announces Plan to Deregister its Common Stock
Post on 3/28/17
Philadelphia
